Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
GAITHERSBURG, Md., Aug. 1 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) announced today that its stockholders approved the merger of Iomai with a wholly-owned subsidiary of Intercell...
GAITHERSBURG, Md. and VIENNA, June 19 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) announced that its Chief Scientific Officer, Gregory Glenn, M.D., and Alexander Von Gabain, Ph...
GAITHERSBURG, Md. and VIENNA, Austria, June 11 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) today announced the publication of data from the company's positive Phase II field study...
GAITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) today said that it will host a conference call and live webcast tomorrow to discuss today's announcement that...
- Intercell AG ('Intercell') to acquire Iomai Corporation ('Iomai') in a fully recommended share/cash transaction for USD 6.60 per share of Iomai's common stock representing a fully diluted equity...
- Dose-Ranging Trial to Further Assess Feasibility of Dose-sparing and Single-Dose Vaccination Against H5N1 Flu - GAITHERSBURG, Md., April 15 /PRNewswire-FirstCall/ -- Iomai Corporation...
- Grant to Cover Formulation Work, Stability Characterization of Dry-Patch Vaccine -
- Merck to Conduct Preclinical Proof-of-Principle Studies - GAITHERSBURG, Md., April 3, 2008 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) today announced that it has signed an...
GAITHERSBURG, Md., March 28 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) today announced, in compliance with NASDAQ marketplace rules, that the independent audit report included in...
- HHS Now Reviewing Data to Determine Next Steps in $128 Million Contract - GAITHERSBURG, Md., March 20 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) today announced positive interim...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
